Study S001373

GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD) - A Pilot Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05356104
Acronym: GAPP-SVD
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: SINGLE
Status: RECRUITING
Enrollment: 110
Start: 2022-05-25
Primary completion: 2027-05
Lead sponsor: Chinese University of Hong Kong
Conditions: Cerebral Small Vessel Disease
Interventions: DRUG:GLP-1 receptor agonist
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change of Brain Peak Width of Skeletonized Mean Diffusivity [Baseline and week 78]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.